Preview

Bulletin Physiology and Pathology of Respiration

Advanced search

DIAGNOSIS AND TREATMENT OF PNEUMONIA IN PATIENTS WITH MULTIPLE MYELOMA

Abstract

The peculiarities of pneumonia in patients with multiple myeloma (MM) were studied. It was found out that pneumonia is a frequent complication of MM (33 patients out of 123 examined ones – 26.8%). Most cases of pneumonia developed in the presence of chronic renal failure and/or agranulocytosis. Pneumonia had a severe course in 61% of MM patients. Diagnosis of pneumonia in patients with MM occurring against agranulocytosis is very difficult as due to the deficiency of granulocytes a clear inflammatory focus which gives a classical physical and radiological picture is not formed in the lungs of these patients. In patients with MM there is a high percentage of nosocomial pneumonia (39%). A severe, prolonged and atypical course of pneumonia in MM is conditioned by granulocytopenia, secondary immunodeficiency, impaired lung excursions due to the deformation of the chest, mielomatose lung affection (paraproteinosis, lymphoid and plasma cell infiltration of the lungs and bronchi, pulmonary fibrosis, emphysema, amyloidosis, mielomatose pleura affection), specific pulmonary manifestations of uremia (nephrogenic edema, uremic pneumonitis and calcification). In accordance with pneumonia occurrence in hospital or out of it, a probable pathogen, clinic-pathogenetic situation, the presence of complications and disorders, a baseline algorithm of empirical treatment of pneumonia in patients with MM was worked out prior to the detection of the pathogen and of its sensitivity to antibiotics as well as for those situations when etiologic diagnosis of pneumonia is not possible.

About the Authors

Valeriy V. Voytsekhovskiy
Amur State Medical Academy
Russian Federation


Yuriy S. Landyshev
Amur State Medical Academy
Russian Federation


Aleksey A. Grigorenko
Amur State Medical Academy
Russian Federation


Tamara S. Savinova
Amur State Medical Academy
Russian Federation


Sergey Yu. Landyshev
Amur State Medical Academy
Russian Federation


Svetlana A. Goryacheva
Amur State Medical Academy
Russian Federation


Vladimir P. Mishuk
Amur State Medical Academy
Russian Federation


References

1. Эффективность бортезомиба при лечении больных рецидивирующей и рефрактерной множественной миеломой (анализ Российских данных исследования eVOBS) / К.М.Абдулкадыров [и др.] // Гематол. и трансфузиол. 2012. №3. С.22–25.

2. Алексеев Г.А., Андреева Н.Е. Миеломная болезнь. М.: Медицина, 1966. 245 с.

3. Андреева Н.Е, Балакирева Т.В. Парапротеинемические гемобластозы // Руководство по гематологии: в 3-х т. Т.2. / под ред. А.И.Воробьева. М.: Ньюдиамед, 2003. С.151–184.

4. Бессмельцев С.С., Абдулкадыров К.М. Множественная миелома. СПб.: Диалект, 2004. 446 с.

5. Войно-Ясенецкая О.В. Легочно-альвеолярный парапротеиноз у больных миеломной болезнью // Пробл. гематол. 1975. №10. С.32–35.

6. Анализ результатов лечения больных множественной миеломой / В.В.Войцеховский [и др.] // Дальневост. мед. журн. 2007. №1. С.47–50.

7. Войцеховский В.В., Ландышев Ю.С., Григоренко А.А. Бронхолегочные осложнения хронического лимфолейкоза и множественной миеломы. Благовещенск: Зея, 2010. 254 с.

8. Нарушение эндобронхиальной микрогемоциркуляции у больных множественной миеломой / В.В.Войцеховский [и др.] // Дальневост. мед. журн. 2010; 2:30–33.

9. Анализ инфекционных осложнений гемобластозов в Амурской области / В.В.Войцеховский [и др.] // Бюл. физиол. и патол. дыхания. 2012. Вып.46. С.64–68.

10. Вотякова О.М., Демина Е.А. Множественная миелома // Клиническая онкогематология / под ред. М.А.Волковой, 2-е изд. М.: Медицина, 2007. С.847–871.

11. Менделеева Л.П., Покровская Л.П. Протокол диагностики и лечения множественной миеломы // Программное лечение заболеваний системы крови / под ред. В.Г.Савченко. М., 2012. С.515–578.

12. Рукавицын О.А., Сидорович Г.И. Множественная миелома и родственные заболевания. М.: БИНОМ, 2006. 212 с.

13. Рукавицын О.А., Сидорович Г.И. Парапротеинемические гемобластозы. М.: ГЭОТАР-Медиа, 2008. 304 с.

14. Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma / M.Offidani [et al.] // Blood. 2006. Vol.108, №7. Р.2159–2164.

15. Lenalidomide plus high-dose dexamethasone versus Lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomized controlled trial / S.V.Rajkumar [et al.] // Lancet Oncol. 2010. Vol.11, №1. P.29–37.


Review

For citations:


Voytsekhovskiy V.V., Landyshev Yu.S., Grigorenko A.A., Savinova T.S., Landyshev S.Yu., Goryacheva S.A., Mishuk V.P. DIAGNOSIS AND TREATMENT OF PNEUMONIA IN PATIENTS WITH MULTIPLE MYELOMA. Bulletin Physiology and Pathology of Respiration. 2013;(50):23-29. (In Russ.)

Views: 634


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1998-5029 (Print)